Clinical Trials Browser

Phase 2 × Recurrence × denileukin diftitox × Clear all

NCT00801918 2013-05-15

Denileukine Diftitox for Relapsed ALCL

Phase 2 Withdrawn

Lymphoma, Recurrence, Lymphoma, Large-Cell, Anaplastic